Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EK9788 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Sudden death
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: L-THYROXINE [LEVOTHYROXINE SODIUM]; NEUROBION [CYANOCOBALAMIN;PYRIDOXINE HYDROCHLORIDE;THIAMINE DISULFIDE]; EMCORETIC; PRAREDUCT; ROCALTROL; CO-BISOPROLOL; SERTRALINE EG; TRAZODONE EG; LYSANXIA; OZEMPIC; L-THYROXINE [LEVOTHYROXINE SODIUM];
Current Illness: Cerebral atrophy; Hyperparathyroidism; Hypocalcemia; Malabsorption; Osteopenia; Supraventricular extrasystoles; Ventricular extrasystoles
Preexisting Conditions: Medical History/Concurrent Conditions: Algoneurodystrophy (complex regional pain syndrome); Bypass surgery; Cataract (left); Depression; Eventration repair; Gastric banding; Radius fracture; Skull fracture; Thyroidectomy total; Total knee replacement
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021266825
Write-up: death in her sleep on day 5; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB BE-FAMHP-DHH-N2021-79852. A 73-year-old female patient received the second dose of BNT162B2 (COMIRNATY, lot number EK9788) via an unspecified route of administration on 18Feb2021 at single dose for COVID-19 immunisation. Medical history included fronto-parietal atrophy from 18Sep2020 and ongoing; isolated supraventricular extrasystoles from 21Sep2020 and ongoing; rare ventricular extrasystoles from 21Sep2020 and ongoing; hyperparathyroidism due to hypocalcemia (malabsorption phenomenon) from 01Jan2010 and ongoing; mixed osteopenia from 19Mar2020 and ongoing; algoneurodystrophy on right total knee replacement (complex regional pain syndrome) from 01Jan2014 to 01Jan2017; depression on 01Jan2000 (as reported); head fracture right radius on 04Dec2016; gastric banding on 01Jan2000; bypass on 01Jan2009; left eye cataract on 02Mar2016; eventration cure from an unspecified date to 17Dec2020; right total knee replacement on 01Jan2014, and total thyroidectomy on 01Jan2000. Concomitant medications included levothyroxine sodium (L-THYROXINE) from 21Dec2020; cyanocobalamin, pyridoxine hydrochloride, thiamine disulfide (NEUROBION) from 09Mar2020; bisoprolol fumarate, hydrochlorothiazide (EMCORETIC) from 09Mar2020; pravastatin sodium (PRAREDUCT) from 09Mar2020; calcitriol (ROCALTROL) from 09Mar2020; bisoprolol fumarate, hydrochlorothiazide (CO-BISOPROLOL) from 20Oct2020; sertraline hydrochloride (SERTRALINE EG) from 17Dec2020; trazodone hydrochloride (TRAZODONE EG) from 17Dec2020; prazepam (LYSANXIA) from 11Sep2020; semaglutide (OZEMPIC) from an unspecified date; levothyroxine sodium (L-THYROXINE) from 20Oct2020; ferrous sulfate (FERO-GRADUMET) from 09Mar2020, all for unspecified indication. The patient experienced death in her sleep on day 5 on 23Feb2021. An autopsy was not performed. The Regulatory Authority considered the causality of the sudden death with Comirnaty as unclassifiable. Reporter Comment: No particular fragility: completely autonomous patient, no mobility problem, no cognitive disorders. She had little medical history that could explain such a sudden death. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: No particular fragility: completely autonomous patient, no mobility problem, no cognitive disorders. She had little medical history that could explain such a sudden death.; Reported Cause(s) of Death: death in her sleep on day 5
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166